BIOGEN INC. — Income Charts
71 quarters of history · ending 2025-12-31 · SEC EDGAR
Revenue↓-7.1% -$175M
$2.28B
Cost of Revenue↓-15.1% -$88M
$496M
Gross Profit↓-26.7% -$862M
$2.36B
R&D↑+8.2% +$39M
$509M
SG&A↑+0.4% +$3M
$683M
D&A↑+8.8% +$16M
$200M
Operating Income↓-37.3% -$363M
$611M
EBITDA↑+8.8% +$16M
$200M
Interest Expense↑+12.5% +$8M
$68M
Pretax Income↑+23.6% +$106M
$557M
Tax Provision↑+45.3% +$28M
$91M
Net Income↑+20.1% +$78M
$467M
Gross Margin↓-5.0pts
82.8%
Operating Margin↓-12.0pts
24.1%
Net Margin↑+2.6pts
18.4%